On June 22-24th, 2020, two of our distinguished PharmD students, Fatiha Hammed and Dalia Alsaeedy co-authored a poster presented in the late breaking section in the annual meeting of the American Association of Cancer Research (AACR). The AACR annual meeting is the largest scientific worldwide conference for cancer research and all accepted abstracts are published as a proceeding in “Cancer Research” Journal which carries an Impact Factor of 8.378. The poster describes the anticancer pharmacological profiling for novel compounds designed and synthesized by Dr. Ahmed T. Negmeldin, Assistant Professor of Medicinal Chemistry , College of Pharmacy, Gulf Medical University (GMU).

Fatiha and Dalia undertook a significant portion of the pharmacological assessment of the compounds under the supervision of Dr. Ahmed Al-Abd, Associate Professor of Pharmacology, College of Pharmacy, GMU. This research project was supported by an internal grant from GMU. Fatiha and Dalia took their wet-lab training and performed the experiments related to this research within Thumbay Research Institute for Precision Medicine (TRIPM) at GMU.
Fatiha commented: I have always been passionate about research and I feel grateful to have learned so much under the tutelage of Dr. Ahmed Al-Abd. I believe this will be a milestone in my pursuit of a research career.
Dalia commented: This experience further solidified my interest in scientific research. I’m very lucky and grateful to have been allowed this opportunity.
The PharmD students’ supervisor, Dr. Ahmed Al-Abd added: Fatiha and Dalia are my first GMU Scientific Kids and I am very proud of them.
Professor Sherief Khalifa, Dean College of Pharmacy and Vice Chancellor for Quality and Global Engagement commented: It is great to see some of our students on track to become research scientists who will make important contributions to science and human health in years to come.